The effect of 250 mg of diphenylhydantoin, administered intravenously, on left ventricular function was determined during cardiac catheterization in nine patients with heart disease.
amide, two of the most commonly used antiarrhythmic agents, have been reported to depress myocardial function.'-4 Furthermore it is well recognized that significant systemic hypotension may accompany their intravenous administration.
It has been demonstrated by several investigators that diphenylhydantoin also is effective in abolishing many cardiac arrhythmias. 5 In spite of its increasing use, only a single systematic study of the hemodynamic effects of this drug in man has been done, measurements being limited to systemic and pulmonary arterial pressures and cardiac output.8 Although significant changes in these parameters were not produced by the intravenous administration of this agent, it has been demonstrated conclusively that a negative inotropic effect does occur in the laboratory animal.9-11 Since changes in the contractile state of the myocardium can occur that will not necessarily produce changes in cardiac output, it was proposed that the effect of diphenylhydantoin on ventricular function in man be examined in greater detail. Furthermore, in order to be of more clinical significance, this study was done only in patients with heart disease, since the arrhythmias for which the drug is given intravenously usually occur in patients with impaired myocardial function.
Methods Studies were performed in nine patients, ranging in age from 42 to 66 years (average, 52 years). One patient (W. H.) had hypertensive heart disease, one (H. C.) aortic stenosis, and the remaining seven had primary myocardial disease. All patients except H. C. had cardiomegaly and a history of congestive heart failure, and were receiving a digitalis glycoside. Clinically, none of the patients had evidence of congestive heart failure at the time of the study. Patient H. C., with aortic stenosis, had electrocardiographic evidence of left ventricular hypertrophy and was also receiving a digitalis preparation. All patients had sinus rhythm.
After Statistical analyses were performed using Student's paired t test.12
Results
The hemodynamic data before and after diphenylhydantoin for each individual are presented in table 1, and figure 1 illustrates the mean changes in various parameters. It must be appreciated that the mean values for the hemodynamic data at the 10-minute period are based on observations in only eight of the nine patients. Since calculation of all mean values using only the data from the eight patients in whom complete studies were obtained produced no appreciable change in the results, this method of presentation seems valid. Left ventricular end-diastolic (LVED) pressure at rest was normal in each patient, averaging 6.0 mm Hg. However, the cardiac index (CI) was reduced (<2.5 L/min/M2) in four patients and averaged 2.5 L/min/M2. Five minutes after completion of the drug infusion, LVED pressure had risen in each patient to an average of 10 mm Hg, an increase which is statistically significant ( power index in g-M/sec/M2; SVI, stroke volume index in ml/M2; dp/dt, maximum rate of rise of left ventricu- thus myocardial function was depressed. Further evidence to support this observation was obtained from the changes that occurred in maximum dp/dt, a decrease occurring in eight of nine patients. Although several factors affect dp/dt, it seems probable that only a decrease in the contractile state of the myocardium would account for the reduction in dp/dt observed in this study. The increase in LVED pressure, which occurred in each patient, and the increase in heart rate, which occurred in six of nine patients, would by themselves tend to increase maximum dp/dt.2' A fall in resistance to left ventricular ejection, which would decrease dp/dt2' if maximum dp/dt should occur after opening of the aortic valve, did occur in most patients. However, these changes were small, and systemic pressure had returned to near control values after 10 minutes at which time dp/dt was still reduced significantly. It is of interest that an increase in heart rate, LVED pressure, and systemic pressure occurred in the patient in whom dp/dt was unchanged at the 5-minute period. Since each of these changes would tend to increase dp/dt, the absence of a rise in dp/dt in this patient would indicate that myocardial function was depressed at this time.
Inherent in the conclusion that diphenylhydantoin depresses myocardial function is the assumption that the increase in LVED pressure reflects an increase in LVED volume and not an acutely induced change in ventricular distensibility. Increases in heart rate have been reported to decrease myocardial distensibility.22 However, this has occurred only with increases in heart rate of much greater magnitude than those observed in this study. Recently it was observed in an isolated muscle preparation that changes in afterload could alter the resting length-tension relationship of the myocardium.23 However, this has not been observed in animals with intact circulation. 22 Furthermore, in the present study, falls in systemic arterial pressure following diphenylhydantoin were generally quite small, and LVED pressure remained elevated after systemic pressure had returned to near control values. Thus it appears highly unlikely that changes in heart rate or systemic pressure altered ventricular distensibility to produce the increases observed in LVED pressure. Admittedly there is no information at present as to whether diphenylhydantoin directly affects ventricular compliance. However, animal experiments, in which the force of myocardial contraction has been measured directly9 or in which other factors known to affect ventricular function were carefully controlled,8 have produced results in agreement with the conclusion of this study.
Although diphenylhydantoin does depress myocardial function in patients with heart disease, this effect probably has limited clinical significance. The depression of ventricular function was not of sufficient magnitude to reduce significantly the cardiac output, which is in agreement with the previous study in man.1' Furthermore, the LVED pressure rose to abnormal levels in only four patients, the highest value being 16 mm Hg, and these untoward hemodynamic effects were relatively short-lived. It must be appreciated, however, that more significant and prolonged myocardial depressions might occur in patients with more advanced heart disease than in those of the present study.
Circulation, Volume XXXVI, November 1967 In the present study only small and insignificant decreases in mean arterial pressure were produced by this drug, the maximum fall being 10 mm Hg in patient H. C. with aortic stenosis. This is in agreement with the observations of others using similar doses and methods of administration. 6' 7, 11 Since CI generally was unchanged, this implies that little change occurred in systemic vascular resistance, that is, the drug had little effect on peripheral resistance vessels when administered in this manner. Although a significant peripheral vasodilating effect has been demonstrated in animals,9' 10 the lack of such an effect in man is of distinct clinical significance.
It is difficult to compare quantitatively the circulatory effects of diphenylhydantoin reported herein with those previously reported for procainamide and quinidine. Studies concerning these latter two agents usually have been performed in animals or in man under conditions that are not comparable to those of the present study. Furthermore, quinidine and procainamide often have been given to animals more rapidly and in amounts larger than those employed clinically. However, several investigators have reported that these agents also depress myocardial function.14 Also, it has been observed that intravenous procainamide reduces the cardiac output in patients with heart disease,24 but cardiac output is unchanged or even increased following the oral administration of quinidine to both normal subjects and patients with heart disease. 25 Comments on the Medical Library In respect to human population we may look forward hopefully to birth control, but in respect to the population of the library I see no solution in the foreseeable future except to reply on informed but brutal selection of only that material proper to medical science and practice. It would be appropriate to start a discussion of this selective process by defining medicine, but this is difficult to do. Webster's definition of medicine as "the science and art dealing with the prevention, cure and alleviation of disease" is less a definition than a statement of one of its goals. I cannot supply a better definition unless it is to suggest that this goal is to be attained by the study of 
